NAPO PHARMACEUTICALS INC
Related Filers (1)
Other (20)
D
Friday, 6/6/2014
Exempt (Private) Offering
D
Thursday, 10/27/2011
Exempt (Private) Offering
D
Wednesday, 6/22/2011
Exempt (Private) Offering
D
Wednesday, 10/27/2010
Exempt (Private) Offering
D
Thursday, 7/9/2009
Exempt (Private) Offering
REGDEX
Monday, 3/16/2009
Form D (PDF)
REGDEX
Monday, 3/16/2009
Form D (PDF)
REGDEX
Monday, 3/16/2009
Form D (PDF)
REGDEX
Wednesday, 10/29/2008
Form D (PDF)
REGDEX
Wednesday, 10/29/2008
Form D (PDF)
REGDEX
Wednesday, 10/29/2008
Form D (PDF)
REGDEX
Wednesday, 10/29/2008
Form D (PDF)
REGDEX/A
Wednesday, 12/19/2007
Form D (PDF)
REGDEX
Tuesday, 11/13/2007
Form D (PDF)
REGDEX/A
Friday, 2/16/2007
Form D (PDF)
REGDEX
Monday, 11/13/2006
Form D (PDF)
REGDEX
Wednesday, 12/28/2005
Form D (PDF)
REGDEX
Wednesday, 12/28/2005
Form D (PDF)
REGDEX
Tuesday, 3/30/2004
Form D (PDF)
REGDEX/A
Monday, 9/9/2002
Form D (PDF)
Ownership (2)
SC 13G
Tuesday, 3/29/2016
Jaguar Animal Health, Inc.: Major Shareholders
3
Wednesday, 5/13/2015
Jaguar Animal Health, Inc.: Initial statement of beneficial ownership of securities
Prospectus (5)
425
Friday, 7/7/2017
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Wednesday, 6/7/2017
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Thursday, 4/6/2017
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Friday, 3/31/2017
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Tuesday, 2/21/2017
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions